Initial dose of three monthly intravitreal injections versus PRN intravitreal injections of bevacizumab for macular edema secondary to branch retinal vein occlusion

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Ahn, Seong Joon ^a   Ahn, Jeeyun ^a,b   Woo, Se Joon ^a   Park, Kyu Hyung ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; COMPARATIVE EFFECTIVENESS; DOSAGE SCHEDULE COMPARISON; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETINA DETACHMENT; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; UVEITIS; VISUAL ACUITY; VITREOUS HEMORRHAGE; AGED; DRUG EFFECT; EYE; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; RETINA VEIN OCCLUSION; TREATMENT OUTCOME; VASCULARIZATION;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; EYE; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84884548010     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/209735     Document Type: Article

References (31)

1. Greer D. V., Constable I. J., Cooper R. L., Macular oedema and retinal branch vein occlusion. Australian Journal of Ophthalmology 1980 8 3 207 209 2-s2.0-0019143669
2. Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. American Journal of Ophthalmology 1984 98 3 271 282
3. Scott I. U., Ip M. S., VanVeldhuisen P. C., Oden N. L., Blodi B. A., Fisher M., Chan C. K., Gonzalez V. H., Singerman L. J., Tolentino M., A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care versus corticosteroid for retinal vein occlusion (SCORE) study report 6. Archives of Ophthalmology 2009 127 9 1115 1128 2-s2.0-70349247768 10.1001/archophthalmol.2009.233
4. Park D. H., Kim I. T., Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. Retina 2010 30 1 117 124 2-s2.0-75149150342 10.1097/IAE.0b013e3181bced68
5. Ma J., Yao K., Zhang Z., Tang X., 25-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic cystoid macular edema associated with branch retinal vein occlusion. Retina 2008 28 7 947 956 2-s2.0-67949109587 10.1097/IAE.0b013e31816c683d
6. Funk M., Kriechbaum K., Prager F., Benesch T., Georgopoulos M., Zlabinger G. J., Schmidt-Erfurth U., Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Investigative Ophthalmology and Visual Science 2009 50 3 1025 1032 2-s2.0-62649161064 10.1167/iovs.08-2510
7. Krohne T. U., Eter N., Holz F. G., Meyer C. H., Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. American Journal of Ophthalmology 2008 146 4 508 512 2-s2.0-51649109046 10.1016/j.ajo.2008.05.036
8. Noma H., Funatsu H., Yamasaki M., Tsukamoto H., Mimura T., Sone T., Hirayama T., Tamura H., Yamashita H., Minamoto A., Mishima H. K., Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 2008 22 1 42 48 2-s2.0-38349179299 10.1038/sj.eye.6702498
9. Campochiaro P. A., Hafiz G., Channa R., Shah S. M., Nguyen Q. D., Ying H., Do D. V., Zimmer-Galler I., Solomon S. D., Sung J. U., Syed B., Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes. Ophthalmology 2010 117 12 2387.e5 2394.e5 2-s2.0-78649880482 10.1016/j.ophtha.2010.03.060
10. Campochiaro P. A., Heier J. S., Feiner L., Gray S., Saroj N., Rundle A. C., Murahashi W. Y., Rubio R. G., Ranibizumab for macular edema following branch retinal vein occlusion. Six-month primary end point results of a phase III study. Ophthalmology 2010 117 6 1102.e1 1112.e1 2-s2.0-77952891051 10.1016/j.ophtha.2010.02.021
11. Brown D. M., Campochiaro P. A., Bhisitkul R. B., Ho A. C., Gray S., Saroj N., Adamis A. P., Rubio R. G., Murahashi W. Y., Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 2011 118 8 1594 1602 2-s2.0-79958817527 10.1016/j.ophtha.2011.02.022
12. Roh M. I., Byeon S. H., Kwon O. W., Repeated intravitreal injection of bevacizumab for clinically significant diabetic macular edema. Retina 2008 28 9 1314 1318 2-s2.0-63549146725 10.1097/IAE.0b013e3181853d2a
13. Ziemssen F., Deuter C. M., Stuebiger N., Zierhut M., Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin). Graefe's Archive for Clinical and Experimental Ophthalmology 2007 245 6 917 918 2-s2.0-34247276408 10.1007/s00417-006-0512-2
14. Chung E. J., Hong Y. T., Lee S. C., Kwon O. W., Koh H. J., Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology 2008 246 9 1241 1247 2-s2.0-48449106803 10.1007/s00417-008-0866-8
15. Figueroa M. S., Contreras I., Noval S., Arruabarrena C., Results of bevacizumab as the primary treatment for retinal vein occlusions. British Journal of Ophthalmology 2010 94 8 1052 1056 2-s2.0-77955243577 10.1136/bjo.2009.173732
16. Rensch F., Jonas J. B., Spandau U. H. M., Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion. Ophthalmologica 2009 223 2 124 127 2-s2.0-57649094780 10.1159/000183844
17. Russo V., Barone A., Conte E., Prascina F., Stella A., Noci N. D., Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion. Retina 2009 29 4 511 515 2-s2.0-66149138872 10.1097/IAE.0b013e318195ca65
18. Beutel J., Ziemssen F., Lüke M., Partsch M., Bartz-Schmidt K.-U., Gelisken F., Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: one-year results. International Ophthalmology 2010 30 1 15 22 2-s2.0-76449106209 10.1007/s10792-008-9282-7
19. Prager F., Michels S., Kriechbaum K., Georgopoulos M., Funk M., Geitzenauer W., Polak K., Schmidt-Erfurth U., Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. British Journal of Ophthalmology 2009 93 4 452 456 2-s2.0-64849111444 10.1136/bjo.2008.141085
20. Spaide R. F., Chang L. K., Klancnik J. M., Yannuzzi L. A., Sorenson J., Slakter J. S., Freund K. B., Klein R., Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. American Journal of Ophthalmology 2009 147 2 298 306 2-s2.0-58349122638 10.1016/j.ajo.2008.08.016
21. Guthoff R., Meigen T., Hennemann K., Schrader W., Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis. Ophthalmologica 2010 224 5 319 324 2-s2.0-77951240776 10.1159/000313304
22. Rabena M. D., Pieramici D. J., Castellarin A. A., Nasir M. A., Avery R. L., Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007 27 4 419 425 2-s2.0-34247231034 10.1097/IAE.0b013e318030e77e
23. Wu L., Arevalo J. F., Roca J. A., Maia M., Berrocal M. H., Rodriguez F. J., Evans T., Costa R. A., Cardillo J., Comparison of two doses of intravitreal bevacizumab (avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American collaborative retina study group at 6 months of follow-up. Retina 2008 28 2 212 219 2-s2.0-42449094689 10.1097/IAE.0b013e3181619bee
24. Kang H. M., Chung E. J., Kim Y. M., Koh H. J., Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion. Graefe'S Archive For Clinical and Experimental Ophthalmology 2013 251 2 501 508
25. Domalpally A., Peng Q., Danis R., Blodi B., Scott I. U., Ip M., Association of outer retinal layer morphology with visual acuity in patients with retinal vein occlusion: SCORE Study Report 13. Eye 2012 26 7 919 924
26. Gallego-Pinazo R., Dolz-Marco R., Pardo-Lopez D., Ranibizumab for serous macular detachment in branch retinal vein occlusions. Graefe's Archive for Clinical and Experimental Ophthalmology 2013 251 1 9 14
27. Noma H., Funatsu H., Mimura T., Shimada K., Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. Retina 2012 32 9 1844 1852
28. Brown D. M., Campochiaro P. A., Singh R. P., Li Z., Gray S., Saroj N., Rundle A. C., Rubio R. G., Murahashi W. Y., Ranibizumab for macular edema following central retinal vein occlusion. Six-month primary end point results of a phase III study. Ophthalmology 2010 117 6 1124.e1 1133.e1 2-s2.0-77952889477 10.1016/j.ophtha.2010.02.022
29. Terui T., Kondo M., Sugita T., Ito Y., Kondo N., Ota I., Miyake K., Terasaki H., Changes in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch retinal vein occlusion. Retina 2011 31 6 1068 1074 2-s2.0-79958283169 10.1097/IAE.0b013e31820c83c2
30. Heier J. S., Campochiaro P. A., Yau L., Li Z., Saroj N., Rubio R. G., Lai P., Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology 2012 119 4 802 809 2-s2.0-84859269800 10.1016/j.ophtha.2011.12.005
31. Falkenstein I. A., Cochran D. E., Azen S. P., Dustin L., Tammewar A. M., Kozak I., Freeman W. R., Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts. Ophthalmology 2008 115 2 319 323 2-s2.0-38549147648 10.1016/j.ophtha.2007.05.028